Reward System Dysfunction as a Neural Substrate of Symptom Expression Across the General Population and Patients with Schizophrenia

Schizophrenia Bulletin

Volumn 41, Issue 6, 2015, Pages 1370-1378

  Simon, Joe J ^a   Cordeiro, Sheila A ^a   Weber, Marc Andre ^b   Friederich, Hans Christoph ^a,c   Wolf, Robert C ^a,d   Weisbrod, Matthias ^a,e   Kaiser, Stefan ^f  

^a Centre for Psychosocial Medicine   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

^d SAARLAND UNIVERSITY   (Germany)

^e Institute of Pathology   (Germany)

^f UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

Author keywords

Apathy; Cued reinforcement reaction time task; Dimensional symptom expression; Functional magnetic resonance imaging; Psychosislike symptom expression; Ventral striatum

Indexed keywords

ADULT; ANTICIPATION; APATHY; ARTICLE; CLINICAL ARTICLE; CONNECTOME; CONTROLLED STUDY; CUED REINFORCEMENT REACTION TIME TASK; EVENT RELATED POTENTIAL; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; HUMAN; MALE; MEDIAL ORBITOFRONTAL CORTEX; MENTAL PATIENT; NUCLEAR MAGNETIC RESONANCE SCANNER; POPULATION; PRIORITY JOURNAL; PSYCHOSIS; REINFORCEMENT; RESPONSE TIME; REWARD; SCHIZOPHRENIA; SYMPTOM; TASK PERFORMANCE; VENTRAL STRIATUM; NERVE CELL NETWORK; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSIOLOGY; PREFRONTAL CORTEX; YOUNG ADULT;

ADULT; ANTICIPATION, PSYCHOLOGICAL; APATHY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NERVE NET; PREFRONTAL CORTEX; PSYCHOTIC DISORDERS; REWARD; SCHIZOPHRENIA; VENTRAL STRIATUM; YOUNG ADULT;

EID: 84946148514     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbv067     Document Type: Article

References (50)

1. Rössler W, Riecher-Rössler A, Angst J, et al. Psychotic experiences in the general population: a twenty-year prospective community study. Schizophr Res. 2007;92:1-14.
2. van Os J, Linscott RJ, Myin-Germeys I, Delespaul P, Krabbendam L. A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis pronenesspersistence-impairment model of psychotic disorder. Psychol Med. 2009;39:179-195.
3. Dominguez MD, Wichers M, Lieb R, Wittchen HU, van Os J. Evidence that onset of clinical psychosis is an outcome of progressively more persistent subclinical psychotic experiences: an 8-year cohort study. Schizophr Bull. 2011;37:84-93.
4. Linscott RJ, van Os J. An updated and conservative systematic review and meta-analysis of epidemiological evidence on psychotic experiences in children and adults: on the pathway from proneness to persistence to dimensional expression across mental disorders. Psychol Med. 2013;43:1133-1149.
5. Kaiser S, Heekeren K, Simon JJ. The negative symptoms of schizophrenia: category or continuum? Psychopathology. 2011;44:345-353.
6. Linscott RJ, van Os J. Systematic reviews of categorical versus continuum models in psychosis: evidence for discontinuous subpopulations underlying a psychometric continuum. Implications for DSM-V, DSM-VI, and DSM-VII. Annu Rev Clin Psychol. 2010;6:391-419.
7. David AS. Why we need more debate on whether psychotic symptoms lie on a continuum with normality. Psychol Med. 2010;40:1935-1942.
8. Modinos G, Renken R, Ormel J, Aleman A. Self-reflection and the psychosis-prone brain: an fMRI study. Neuropsychology. 2011;25:295-305.
9. Corlett PR, Fletcher PC. The neurobiology of schizotypy: fronto-striatal prediction error signal correlates with delusion-like beliefs in healthy people. Neuropsychologia. 2012;50:3612-3620.
10. Kumari V, Antonova E, Geyer MA. Prepulse inhibition and "psychosis-proneness" in healthy individuals: an fMRI study. Eur Psychiatry. 2008;23:274-280.
11. Howes OD, Kapur S. The dopamine hypothesis of schizophrenia: version III-the final common pathway. Schizophr Bull. 2009;35:549-562.
12. Hirvonen J, van Erp TG, Huttunen J, et al. Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia. Arch Gen Psychiatry. 2005;62:371-378.
13. Nielsen MO, Rostrup E, Wulff S, et al. Alterations of the brain reward system in antipsychotic naïve schizophrenia patients. Biol Psychiatry. 2012;71:898-905.
14. Schlagenhauf F, Sterzer P, Schmack K, et al. Reward feedback alterations in unmedicated schizophrenia patients: relevance for delusions. Biol Psychiatry. 2009;65:1032-1039.
15. Nielsen MO, Rostrup E, Wulff S, et al. Improvement of brain reward abnormalities by antipsychotic monotherapy in schizophrenia. Arch Gen Psychiatry. 2012;69:1195-1204.
16. Juckel G, Schlagenhauf F, Koslowski M, et al. Dysfunction of ventral striatal reward prediction in schizophrenia. Neuroimage. 2006;29:409-416.
17. Waltz JA, Schweitzer JB, Gold JM, et al. Patients with schizophrenia have a reduced neural response to both unpredictable and predictable primary reinforcers. Neuropsychopharmacology. 2009;34:1567-1577.
18. Simon JJ, Biller A, Walther S, et al. Neural correlates of reward processing in schizophrenia-relationship to apathy and depression. Schizophr Res. 2010;118:154-161.
19. Gradin VB, Waiter G, O'Connor A, et al. Salience networkmidbrain dysconnectivity and blunted reward signals in schizophrenia. Psychiatry Res. 2013;211:104-111.
20. Cools R, Blackwell A, Clark L, Menzies L, Cox S, Robbins TW. Tryptophan depletion disrupts the motivational guidance of goal-directed behavior as a function of trait impulsivity. Neuropsychopharmacology. 2005;30:1362-1373.
21. Stefanis NC, Hanssen M, Smirnis NK, et al. Evidence that three dimensions of psychosis have a distribution in the general population. Psychol Med. 2002;32:347-358.
22. Konings M, Bak M, Hanssen M, van Os J, Krabbendam L. Validity and reliability of the CAPE: a self-report instrument for the measurement of psychotic experiences in the general population. Acta Psychiatr Scand. 2006;114:55-61.
23. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22-33; quiz 34.
24. Andreasen NC, Pressler M, Nopoulos P, Miller D, Ho BC. Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biol Psychiatry. 2010;67:255-262.
25. Gardner DM, Murphy AL, O'Donnell H, Centorrino F, Baldessarini RJ. International consensus study of antipsychotic dosing. Am J Psychiatry. 2010;167:686-693.
26. Andreasen NC. Scale for the Assessment of Negative Symptoms. Iowa City: The University of Iowa; 1983.
27. Sayers SL, Curran PJ, Mueser KT. Factor structure and construct validity of the scale for the assessment of negative symptoms. Psychol. Assess. 1996;8:269-280.
28. Lueken U, Seidl U, Schwarz M, et al. Psychometric properties of a German version of the apathy evaluation scale. Fortschr Neurol Psychiatr. 2006;74:714-722.
29. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261-276.
30. Kronmüller KT, von Bock A, Grupe S, et al. Psychometric evaluation of the Psychotic Symptom Rating Scales. Compr Psychiatry. 2011;52:102-108.
31. Hoppe L. Die "Magical ideation scale": Itemanalyse und Validierung durch eine Untersuchung der Vigilanzleistung (Doctoral dissertation). 1991.
32. Müller MJ, Marx-Dannigkeit P, Schlösser R, Wetzel H, Addington D, Benkert O. The Calgary Depression Rating Scale for Schizophrenia: development and interrater reliability of a German version (CDSS-G). J Psychiatr Res. 1999;33:433-443.
33. Hautzinger M, Keller F, Kühner C. BDI-II. Beck-Depressions-Inventar Revision-Manual. Frankfurt: Harcourt Test Services; 2006.
34. Burgdörfer G, Hautzinger M. [Psychological and social anhedonia. Evaluation of a research instrument for measuring a basic psychopathologic disorder]. Eur Arch Psychiatry Neurol Sci. 1987;236:223-229.
35. Gard DE, Gard MG, Kring AM, John OP. Anticipatory and consummatory components of the experience of pleasure: a scale development study. J. Res. Personal. 2006;40:1086-1102.
36. Lehrl S, Triebig G, Fischer B. Multiple choice vocabulary test MWT as a valid and short test to estimate premorbid intelligence. Acta Neurol Scand. 1995;91:335-345.
37. Tversky A, Kahneman D. Advances in prospect theory: cumulative representation of uncertainty. J. Risk Uncertain. 1992;5:297-323.
38. Nielsen FA, Hansen LK. Automatic Anatomical Labeling of Talairach Coordinates and Generation of Volumes of Interest via tbe Brainmap Database NeuroImage, vol. 16 Presented at the 8th International Conference on Functional Mapping of the Human Brain, June 2-6, 2002, Sendai, Japan. Available on CD-Rom. 2002.
39. Brett M, Anton JL, Valabregue R, Poline JB. Region of interest analysis using the MarsBar toolbox for SPM 99. Neuroimage 2002;16:S497.
40. Friston KJ, Buechel C, Fink GR, Morris J, Rolls E, Dolan RJ. Psychophysiological and modulatory interactions in neuroimaging. Neuroimage. 1997;6:218-229.
41. Berridge KC, Robinson TE. Parsing reward. Trends Neurosci. 2003;26:507-513.
42. Tom SM, Fox CR, Trepel C, Poldrack RA. The neural basis of loss aversion in decision-making under risk. Science. 2007;315:515-518.
43. Kapur S. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry. 2003;160:13-23.
44. Pettersson-Yeo W, Allen P, Benetti S, McGuire P, Mechelli A. Dysconnectivity in schizophrenia: where are we now? Neurosci Biobehav Rev. 2011;35:1110-1124.
45. Stephan KE, Friston KJ, Frith CD. Dysconnection in schizophrenia: from abnormal synaptic plasticity to failures of selfmonitoring. Schizophr Bull. 2009;35:509-527.
46. Bernacer J, Corlett PR, Ramachandra P, et al. Methamphetamine-induced disruption of frontostriatal reward learning signals: relation to psychotic symptoms. Am J Psychiatry. 2013;170:1326-1334.
47. Strauss GP, Frank MJ, Waltz JA, Kasanova Z, Herbener ES, Gold JM. Deficits in positive reinforcement learning and uncertainty-driven exploration are associated with distinct aspects of negative symptoms in schizophrenia. Biol Psychiatry. 2011;69:424-431.
48. Waltz JA, Frank MJ, Robinson BM, Gold JM. Selective reinforcement learning deficits in schizophrenia support predictions from computational models of striatal-cortical dysfunction. Biol Psychiatry. 2007;62:756-764.
49. Simon JJ, Walther S, Fiebach CJ, et al. Neural reward processing is modulated by approach-and avoidance-related personality traits. Neuroimage. 2010;49:1868-1874.
50. Wu CC, Samanez-Larkin GR, Katovich K, Knutson B. Affective traits link to reliable neural markers of incentive anticipation. Neuroimage. 2014;84:279-289.